Diagnosis and detection of pancreatic cancer

Research output: Contribution to journalReview article

Abstract

Computed tomography is the first-line imaging modality for suspected pancreatic cancer. Magnetic resonance cholangiopancreatography is a second-line modality for suspected pancreatic cancer and is usually reserved for equivocal cases. Both computed tomography and MR are highly sensitive in the detection of pancreatic cancer, with up to 96% and 93.5% sensitivity, respectively. Computed tomography is superior to MR in the assessment of tumor resectability, with accuracy rates of up to 86.8% and 78.9%, respectively. Close attention to secondary signs of pancreatic cancer, such as pancreatic duct dilatation, abrupt pancreatic duct caliber change, and parenchymal atrophy, are critical in the diagnosis of pancreatic cancer. Emerging techniques such as radiomics and molecular imaging have the potential of identifying malignant precursors and lead to earlier disease diagnosis. The results of these promising techniques need to be validated in larger clinical studies.

Original languageEnglish (US)
Pages (from-to)333-342
Number of pages10
JournalCancer Journal (United States)
Volume23
Issue number6
DOIs
StatePublished - Nov 1 2017

Fingerprint

Pancreatic Neoplasms
Pancreatic Ducts
Tomography
Magnetic Resonance Cholangiopancreatography
Molecular Imaging
Atrophy
Early Diagnosis
Dilatation
Magnetic Resonance Imaging
Neoplasms

Keywords

  • CT
  • detection
  • EUS
  • MR
  • Pancreatic cancer
  • resectability
  • staging

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Diagnosis and detection of pancreatic cancer. / Chu, Linda Chi Hang; Goggins, Michael S; Fishman, Elliot K.

In: Cancer Journal (United States), Vol. 23, No. 6, 01.11.2017, p. 333-342.

Research output: Contribution to journalReview article

@article{3fc5a235d9d244d38f91062e8aaee4f9,
title = "Diagnosis and detection of pancreatic cancer",
abstract = "Computed tomography is the first-line imaging modality for suspected pancreatic cancer. Magnetic resonance cholangiopancreatography is a second-line modality for suspected pancreatic cancer and is usually reserved for equivocal cases. Both computed tomography and MR are highly sensitive in the detection of pancreatic cancer, with up to 96{\%} and 93.5{\%} sensitivity, respectively. Computed tomography is superior to MR in the assessment of tumor resectability, with accuracy rates of up to 86.8{\%} and 78.9{\%}, respectively. Close attention to secondary signs of pancreatic cancer, such as pancreatic duct dilatation, abrupt pancreatic duct caliber change, and parenchymal atrophy, are critical in the diagnosis of pancreatic cancer. Emerging techniques such as radiomics and molecular imaging have the potential of identifying malignant precursors and lead to earlier disease diagnosis. The results of these promising techniques need to be validated in larger clinical studies.",
keywords = "CT, detection, EUS, MR, Pancreatic cancer, resectability, staging",
author = "Chu, {Linda Chi Hang} and Goggins, {Michael S} and Fishman, {Elliot K}",
year = "2017",
month = "11",
day = "1",
doi = "10.1097/PPO.0000000000000290",
language = "English (US)",
volume = "23",
pages = "333--342",
journal = "Cancer journal (Sudbury, Mass.)",
issn = "0765-7846",
publisher = "Association Pour le Developpement de la Communication Cancerologique",
number = "6",

}

TY - JOUR

T1 - Diagnosis and detection of pancreatic cancer

AU - Chu, Linda Chi Hang

AU - Goggins, Michael S

AU - Fishman, Elliot K

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Computed tomography is the first-line imaging modality for suspected pancreatic cancer. Magnetic resonance cholangiopancreatography is a second-line modality for suspected pancreatic cancer and is usually reserved for equivocal cases. Both computed tomography and MR are highly sensitive in the detection of pancreatic cancer, with up to 96% and 93.5% sensitivity, respectively. Computed tomography is superior to MR in the assessment of tumor resectability, with accuracy rates of up to 86.8% and 78.9%, respectively. Close attention to secondary signs of pancreatic cancer, such as pancreatic duct dilatation, abrupt pancreatic duct caliber change, and parenchymal atrophy, are critical in the diagnosis of pancreatic cancer. Emerging techniques such as radiomics and molecular imaging have the potential of identifying malignant precursors and lead to earlier disease diagnosis. The results of these promising techniques need to be validated in larger clinical studies.

AB - Computed tomography is the first-line imaging modality for suspected pancreatic cancer. Magnetic resonance cholangiopancreatography is a second-line modality for suspected pancreatic cancer and is usually reserved for equivocal cases. Both computed tomography and MR are highly sensitive in the detection of pancreatic cancer, with up to 96% and 93.5% sensitivity, respectively. Computed tomography is superior to MR in the assessment of tumor resectability, with accuracy rates of up to 86.8% and 78.9%, respectively. Close attention to secondary signs of pancreatic cancer, such as pancreatic duct dilatation, abrupt pancreatic duct caliber change, and parenchymal atrophy, are critical in the diagnosis of pancreatic cancer. Emerging techniques such as radiomics and molecular imaging have the potential of identifying malignant precursors and lead to earlier disease diagnosis. The results of these promising techniques need to be validated in larger clinical studies.

KW - CT

KW - detection

KW - EUS

KW - MR

KW - Pancreatic cancer

KW - resectability

KW - staging

UR - http://www.scopus.com/inward/record.url?scp=85037052179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037052179&partnerID=8YFLogxK

U2 - 10.1097/PPO.0000000000000290

DO - 10.1097/PPO.0000000000000290

M3 - Review article

VL - 23

SP - 333

EP - 342

JO - Cancer journal (Sudbury, Mass.)

JF - Cancer journal (Sudbury, Mass.)

SN - 0765-7846

IS - 6

ER -